Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Radiodermatitis 3Head and Neck Neoplasms 3Hypotension 2Stroke 1Shock, Septic 1Optimal Tissue Perfusion 1Neoplasms 1Mouth Neoplasms 1Leiomyoma 1Brain Neoplasms 1Alopecia 1

Interventions

Surveys and Questionnaires 3CG428 2proxalutamide 1efalizumab 1Yoga 1Standard of Care 1Norepinephrine 1Minoxidil 1Low-Level Light Therapy 1Immunoconjugates 1Doxorubicin 1Docetaxel 1Cyproterone Acetate 1Cyclophosphamide 1Cryotherapy 1Coconut Oil 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alopecia × Norepinephrine × Clear all
NCT01367990 2012-03-23

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

ProCertus BioPharm, Inc

Phase 1 Terminated
3 enrolled
Head & Neck

Alopecia, Head and Neck Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡